New in Featured on app

Top 50 Pharmaceutical Companies by R&D Investment Worldwide in 2011

17 May 2013 / By Tim / Clinical Trials, Drug Discovery, Featured on app, Partnering & Investment / 0 comments

The ‘2012 EU Industrial R&D Scoreboard’ highlighted the Pharmaceutical and Biotechnology industry as being the top research and development (R&D) investing sector worldwide. The Scoreboard [...]

 

More in Featured on app

• 

  How to succeed in a stakeholder-driven environment

  16 May 2013 / By Tim / Featured on app, Market Access, Regulation and Government / 0 comments

   
• 

  Human skin cells converted into embryonic stem cells using somatic cell nuclear transfer

  16 May 2013 / By Tim / Featured on app, Regenerative Medicine / 0 comments

   
• 

  Orphan drug Kalydeco now available in Wales

  15 May 2013 / By Tim / Featured on app, Orphan Drugs / 0 comments

   
• 

  Presentation: Challenges of sourcing comparators for biosimilar research and trials

  15 May 2013 / By Tim / Biosimilars, Featured on app / 0 comments

   
• 

  Video: Presentation – Understanding the strategies for delivering consistent operational excellence

  15 May 2013 / By megan / Cell Culture, Featured Videos, Featured on app / 0 comments

   
• 

  Global biosimilar market will grow to $2.44bn this year, says report

  14 May 2013 / By Tim / Biosimilars, Featured on app / 0 comments

   
• 

  Drawn to Science: Stem Cells in Research

  14 May 2013 / By Tim / Featured Videos, Featured on app, Regenerative Medicine / 0 comments

   
• 

  Vertex Kalydeco case: Identifying biomarkers to articulate the value of an orphan drug – Charles Johnson

  14 May 2013 / By Tim / Featured Videos, Featured on app, Orphan Drugs / 0 comments

   
• 

  The challenges and opportunities of first therapies in DMD – Claudia Hirawat

  14 May 2013 / By Tim / Featured Videos, Featured on app, Orphan Drugs / 0 comments

   
• 

  5 Great Acts of Pharma Corporate Social Responsibility

  14 May 2013 / By Tim / Featured on app, Partnering & Investment / 2 comments